OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host Microbiomes in Tumor Precision Medicine: How far are we?
Federica D’Amico, Monica Barone, Teresa Tavella, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 18, pp. 3202-3230
Open Access | Times Cited: 11

Showing 11 citing articles:

Lactoferrin: Antimicrobial impacts, genomic guardian, therapeutic uses and clinical significance for humans and animals
Mohamed E. Abd El‐Hack, Sameh A. Abdelnour, Mahmoud Kamal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114967-114967
Open Access | Times Cited: 24

Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging
Monica Barone, Federica D’Amico, Simone Rampelli, et al.
Mechanisms of Ageing and Development (2022) Vol. 206, pp. 111711-111711
Closed Access | Times Cited: 23

Gut microbiota resilience and recovery after anticancer chemotherapy
Sara Roggiani, Mariachiara Mengoli, Gabriele Conti, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 2, pp. 16-16
Open Access | Times Cited: 11

Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies
Federica D’Amico, Nunzia Decembrino, Edoardo Muratore, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1705-1705
Open Access | Times Cited: 18

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
Giorgia Procaccianti, Sara Roggiani, Gabriele Conti, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 10

Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
Gabriele Conti, Federica D’Amico, Marco Fabbrini, et al.
Genes (2022) Vol. 14, Iss. 1, pp. 55-55
Open Access | Times Cited: 12

Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options
Gloria Ravegnini, Bruno Fosso, Riccardo Ricci, et al.
Cancer Science (2022) Vol. 113, Iss. 8, pp. 2590-2599
Open Access | Times Cited: 8

Probiotics for Inflammatory Bowel Disease; A Deep Dive into Their Impact on Disease Course and Associated Health Risks
Wassan Nori, Methaq Mueen Al-Kaabi, Nabeeha Najatee Akram, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 30, pp. 4807-4825
Closed Access

Gut Microbiota and Chronic Diseases and Conditions
Laura Franza, Rossella Cianci
Current Medicinal Chemistry (2022) Vol. 29, Iss. 18, pp. 3145-3146
Closed Access

Page 1

Scroll to top